| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | CN2887309Y Microcapsule of timulin fumarate |
| 04/11/2007 | CN1946852A Labeling of rapamycin using rapamycin-specific methylases |
| 04/11/2007 | CN1946743A Hyaluronic acid/methotrexate compound |
| 04/11/2007 | CN1946735A Pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid |
| 04/11/2007 | CN1946732A Adenosine receptor agonists |
| 04/11/2007 | CN1946727A (Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents |
| 04/11/2007 | CN1946726A Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/11/2007 | CN1946725A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/11/2007 | CN1946723A Substituted diaza-spiro-[4.5|-decane derivatives and their use as neurokinin antagonists |
| 04/11/2007 | CN1946721A Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof |
| 04/11/2007 | CN1946720A Azabenzofuran substituted thioureas; inhibitors of viral replication |
| 04/11/2007 | CN1946719A Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| 04/11/2007 | CN1946718A Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus |
| 04/11/2007 | CN1946717A Benzimidazole derivative and its use |
| 04/11/2007 | CN1946716A Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 04/11/2007 | CN1946715A Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 04/11/2007 | CN1946714A Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 04/11/2007 | CN1946713A Chemokine receptor antagonists |
| 04/11/2007 | CN1946712A Pyrrolidine derivative |
| 04/11/2007 | CN1946710A Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
| 04/11/2007 | CN1946707A Dibenzo chromene derivatives and their use as ERbeta selective ligands |
| 04/11/2007 | CN1946703A Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| 04/11/2007 | CN1946702A Tri(cyclo) substituted amide compounds |
| 04/11/2007 | CN1946701A Tri-substituted ureas as cytokine inhibitors |
| 04/11/2007 | CN1946700A Tri-substituted ureas as cytokine inhibitors |
| 04/11/2007 | CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins |
| 04/11/2007 | CN1946698A Pyrazole phenyl derivatives as ppar activators |
| 04/11/2007 | CN1946697A Substituted pyrazoline compounds for reducing triglycerides in blood |
| 04/11/2007 | CN1946696A Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/11/2007 | CN1946693A Therapeutic formulations of desoxyepothilones |
| 04/11/2007 | CN1946692A 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946691A Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946690A Cyclobutenedione groups-containing compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946689A Bazedoxifene ascorbate as selective estrogen receptor modulator |
| 04/11/2007 | CN1946688A Atorvastatin calcium in amorphous form |
| 04/11/2007 | CN1946682A Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester |
| 04/11/2007 | CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 04/11/2007 | CN1946679A Amino-propanol derivatives |
| 04/11/2007 | CN1946676A Levalbuterol hydrochloride polymorph b |
| 04/11/2007 | CN1946674A Method for the synthesis of quaternary ammonium compounds and compositions thereof |
| 04/11/2007 | CN1946673A Method of exchanging anions of tetraalkylammonium salts |
| 04/11/2007 | CN1946666A Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| 04/11/2007 | CN1946656A Methods, compositions, and apparatuses for forming macrocyclic compounds |
| 04/11/2007 | CN1946456A Alcohol metabolism moderating composition |
| 04/11/2007 | CN1946452A Frequency assisted transdermal agent delivery method and system |
| 04/11/2007 | CN1946428A Therapeutic antimicrobial compositions and methods |
| 04/11/2007 | CN1946424A Treatment of fungal infections |
| 04/11/2007 | CN1946423A Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/11/2007 | CN1946421A Cancer treatment using viruses and camptothecins |
| 04/11/2007 | CN1946412A Preventive and/or remedy for inflammatory bowel diseases |
| 04/11/2007 | CN1946411A Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination |
| 04/11/2007 | CN1946410A Anti-viral pharmaceutical compositions |
| 04/11/2007 | CN1946409A Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 04/11/2007 | CN1946408A Supportive treatment of liver disease |
| 04/11/2007 | CN1946407A Methods and composition for treating tumors and metastatic disease |
| 04/11/2007 | CN1946406A Novel medicaments for the treatment of respiratory diseases |
| 04/11/2007 | CN1946405A Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives |
| 04/11/2007 | CN1946404A Pharmaceutical compositions for the treatment of sexual disorders II |
| 04/11/2007 | CN1946403A Use of flibanserin in the treatment of premenstrual and other female sexual disorders |
| 04/11/2007 | CN1946402A Piperdine derivatives useful as CCR3 antagonists |
| 04/11/2007 | CN1946401A Alkaloid formulations |
| 04/11/2007 | CN1946400A Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
| 04/11/2007 | CN1946399A Method of treating schizophrenia and/or glucoregulatory abnormalities |
| 04/11/2007 | CN1946398A Thiadiazolidinones as gsk-3 inhibitors |
| 04/11/2007 | CN1946397A Ion channel modulators |
| 04/11/2007 | CN1946396A Medicine for prevention and/or treatment of ischemic circulatory disease |
| 04/11/2007 | CN1946395A 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 04/11/2007 | CN1946394A Injectable composition for the treatment of cancers |
| 04/11/2007 | CN1946393A Preventive and/or therapeutic agent for chronic sinusitis |
| 04/11/2007 | CN1946392A Immunity enhancing agent, anti-cancer agent, and health food containing acethyldiacylglycerole derivatives as an effective ingredient |
| 04/11/2007 | CN1946391A Combinations comprising alpha-2-delta ligands |
| 04/11/2007 | CN1946390A Anti-wrinkle agent |
| 04/11/2007 | CN1946389A Methods and compositions for the treatment of myocardial conditions |
| 04/11/2007 | CN1946388A Therapeutic methods employing nitric oxide precursors |
| 04/11/2007 | CN1946387A Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 04/11/2007 | CN1946386A Combination of deramciclane and opoids as analgesics |
| 04/11/2007 | CN1946385A Use of targeted oxidative therapeutic formulation in treatment of viral diseases |
| 04/11/2007 | CN1946384A Statins for the treatment of ocular hypertension and glaucoma |
| 04/11/2007 | CN1946383A Multi-phase contraceptive preparation based on a natural estrogen |
| 04/11/2007 | CN1946382A Rapid dissolution formulation of a calcium receptor-active compound |
| 04/11/2007 | CN1946379A Prolonged-release compositions comprising torasemide and a matrix-forming polymer |
| 04/11/2007 | CN1946378A Combination dosage forms |
| 04/11/2007 | CN1946376A Coated tablet composition and method of manufacturing the same |
| 04/11/2007 | CN1946372A Use of heat shock protein inhibitors for the reduction of hair growth |
| 04/11/2007 | CN1946353A Naltrexone long acting formulations and methods of use |
| 04/11/2007 | CN1946292A Methods of diminishing co-abuse probability |
| 04/11/2007 | CN1944495A Water gel containing natural high molecule and its radiation preparing method |
| 04/11/2007 | CN1944454A Anti-cancer compound, method for extracting said compound, composition containing said compound, and its use in medicine production |
| 04/11/2007 | CN1944452A 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 04/11/2007 | CN1944448A Puerarin derivative and its medicinal use |
| 04/11/2007 | CN1944442A Preparation of 3,7,10-tri-substuent hetero nitrogen silicon tricyclic and 5-Fu combined substance and its use in pharmacy |
| 04/11/2007 | CN1944433A 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1944432A 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1944430A Anti-cancer active compound depside peptide as derivative of natural product |
| 04/11/2007 | CN1944428A Chroman compound and its preparing method and use in producing medicine |
| 04/11/2007 | CN1944424A Aryl formyl piperazine compound and its preparing method and use in medicine production |
| 04/11/2007 | CN1944420A Iguratimod crystal form and its composition |
| 04/11/2007 | CN1944417A Five-membered-ring compound |
| 04/11/2007 | CN1944416A Benzimidazole compound and its preparing method and use in medicine production |